SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-17-000065
Filing Date
2017-08-01
Accepted
2017-08-01 16:10:14
Documents
3
Period of Report
2017-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - EARNINGS RELEASE ocera-form8xkxearningsrele.htm 8-K 28687
2 EXHIBIT 99.1 exhibit991oceraearningsrel.htm EX-99.1 98706
3 oceralogoa31.jpg GRAPHIC 11170
  Complete submission text file 0001274644-17-000065.txt   144045
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 17996828
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences